NL-OMON47401招募中不适用
Validation of Pharmacokinetic and Pharmacodynamic Assays for determination of Nivolumab and Pembrolizumab concentrations, and the occupancy of their target receptor Programmed Death-1 (PD-1) on T-cells - Developing Assays for Anti-PD-1 monoclonal antibodies
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational invasive
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients with solid tumors who will start treatment with nivolumab or pembrolizumab and are willing to undergo blood sampling and/or donate residual material.
排除标准
- •Patients with known alcoholism, drug addiction, psychotic disorders in the history and/or other reasons, for which they are not amendable for adequate follow up.
- •Uncontrolled infectious disease or known HIV-1 or HIV-2 type patients.
研究者
相似试验
进行中（未招募）
不适用
Evaluation of pharmacokinetic and pharmacodynamic interactions between escitalopram and drugs used for the treatment of bipolar disorders. - NDbipolar disordersMedDRA version: 9.1Level: LLTClassification code 10057667Term: Bipolar disorderEUCTR2008-000370-20-ITAZIENDA OSPEDALIERA PISANA
尚未招募
不适用
Examining the pharmacokinetic and pharmacodynamic profile of biperidegeheugen/ memoryNL-OMON24672Maastricht University27
招募中
不适用
Examining the pharmacokinetic and pharmacodynamic profile of biperidememory impairmentNL-OMON47428niversiteit Maastricht42
尚未招募
不适用
A study on the pharmacokinetics and pharmacodynamics of remimazolam during total intravenous anesthesia with remifentanilKCT0007066Inje University Busan Paik Hospital15
尚未招募
不适用
A Clinical Trial for Evaluation of Pharmacokinetic interaction between WS1313D and NAC after Co-administration in Healthy Male Adult SubjectsDiseases of the nervous systemKCT0004878Woosung Pharma27